Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.55M Buy
162,509
+110,489
+212% +$3.69M ﹤0.01% 2039
2026
Q1
$1.56M Sell
52,020
-5,186
-9% -$121K ﹤0.01% 2368
2025
Q4
$1.3M Buy
57,206
+2,476
+5% +$66.8K ﹤0.01% 2483
2025
Q3
$1.52M Buy
54,730
+529
+1% +$16.6K ﹤0.01% 2417
2025
Q2
$1.98M Sell
54,201
-1,253
-2% -$58.5K ﹤0.01% 2303
2025
Q1
$2.34M Buy
55,454
+21,687
+64% +$1.27M ﹤0.01% 2276
2024
Q4
$2.2M Buy
33,767
+13,170
+64% +$915K ﹤0.01% 2351
2024
Q3
$1.27M Sell
20,597
-19,828
-49% -$1.2M ﹤0.01% 2648
2024
Q2
$3.04M Buy
+40,425
New +$3.77M ﹤0.01% 2181

Other funds holding IBTA

Nuveen's IBTA Position: Q2 2026 in Review

Nuveen increased its Ibotta (IBTA) stake by 212% in Q2 2026, buying an estimated $3.69M and bringing the position to 162,509 shares worth $5.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

Nuveen first reported a position in IBTA in Q2 2024 and has held it in 9 quarters since. 147 funds tracked by Wall St. Rank hold IBTA as of Q2 2026.

  • Nuveen held 162,509 shares of Ibotta worth $5.55M as of Q2 2026.
  • Nuveen bought 110,489 Ibotta shares in Q2 2026, an estimated $3.69M.
  • Ibotta made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2039 holding.
  • Nuveen first reported a position in Ibotta in Q2 2024 and has held it in 9 quarters since.
  • 147 funds tracked by Wall St. Rank held Ibotta as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.